Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$70.91
-0.28-0.39%
At close: -
$70.94
0.030.04%
After Hours: Mar 28, 6:07 PM EDT
Comments
Loading...
Edwards Lifesciences Analyst Ratings and Price Targets | NYSE:EW | Benzinga
Edwards Lifesciences Corp has a consensus price target of $79.73 based on the ratings of 23 analysts. The high is $105 issued by Mizuho on April 11, 2024. The low is $60 issued by Wolfe Research on January 16, 2025. The 3 most-recent analyst ratings were released by Barclays, Canaccord Genuity, and RBC Capital on February 13, 2025, February 13, 2025, and February 12, 2025, respectively. With an average price target of $82 between Barclays, Canaccord Genuity, and RBC Capital, there's an implied 15.59% upside for Edwards Lifesciences Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Barclays
Canaccord Genuity
RBC Capital
Piper Sandler
Evercore ISI Group
1calculated from analyst ratings
Analyst Ratings for Edwards Lifesciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/13/2025 | Buy Now | 26.87% | Barclays | Matt Miksic67% | $88 → $90 | Maintains | Overweight | Get Alert |
| 02/13/2025 | Buy Now | 0.08% | Canaccord Genuity | William Plovanic58% | $68 → $71 | Maintains | Hold | Get Alert |
| 02/12/2025 | Buy Now | 19.82% | RBC Capital | Shagun Singh57% | $85 → $85 | Reiterates | Outperform → Outperform | Get Alert |
| 02/12/2025 | Buy Now | 2.9% | Piper Sandler | Adam Maeder65% | $70 → $73 | Maintains | Neutral | Get Alert |
| 02/12/2025 | Buy Now | 2.9% | Evercore ISI Group | Vijay Kumar53% | $75 → $73 | Maintains | In-Line | Get Alert |
| 02/12/2025 | Buy Now | 5.72% | Morgan Stanley | Patrick Wood53% | $70 → $75 | Maintains | Equal-Weight | Get Alert |
| 01/30/2025 | Buy Now | 26.87% | Stifel | Rick Wise74% | $75 → $90 | Upgrade | Hold → Buy | Get Alert |
| 01/16/2025 | Buy Now | -15.42% | Wolfe Research | Mike Polark55% | $60 → $60 | Downgrade | Peer Perform → Underperform | Get Alert |
| 12/16/2024 | Buy Now | 26.87% | B of A Securities | Travis Steed59% | $82 → $90 | Upgrade | Neutral → Buy | Get Alert |
| 12/11/2024 | Buy Now | 17% | Citigroup | Joanne Wuensch75% | $81 → $83 | Maintains | Buy | Get Alert |
| 12/05/2024 | Buy Now | 26.87% | Goldman Sachs | David Roman37% | $81 → $90 | Maintains | Buy | Get Alert |
| 12/05/2024 | Buy Now | 9.95% | Truist Securities | Richard Newitter74% | $70 → $78 | Reiterates | Hold → Hold | Get Alert |
| 12/05/2024 | Buy Now | 5.72% | Stifel | Rick Wise74% | $70 → $75 | Maintains | Hold | Get Alert |
| 12/05/2024 | Buy Now | 19.82% | RBC Capital | Shagun Singh57% | $80 → $85 | Maintains | Outperform | Get Alert |
| 12/05/2024 | Buy Now | -4.14% | Canaccord Genuity | William Plovanic58% | $63 → $68 | Maintains | Hold | Get Alert |
| 12/02/2024 | Buy Now | 24.05% | Barclays | Matt Miksic67% | $85 → $88 | Maintains | Overweight | Get Alert |
| 11/27/2024 | Buy Now | 12.77% | RBC Capital | Shagun Singh57% | $75 → $80 | Maintains | Outperform | Get Alert |
| 10/25/2024 | Buy Now | -11.19% | Canaccord Genuity | William Plovanic58% | $66 → $63 | Maintains | Hold | Get Alert |
| 10/25/2024 | Buy Now | 9.95% | JP Morgan | Robbie Marcus67% | $72 → $78 | Maintains | Neutral | Get Alert |
| 10/25/2024 | Buy Now | -1.33% | Piper Sandler | Adam Maeder65% | $73 → $70 | Maintains | Neutral | Get Alert |
| 10/25/2024 | Buy Now | -1.33% | Truist Securities | Richard Newitter74% | $71 → $70 | Maintains | Hold | Get Alert |
| 10/25/2024 | Buy Now | -4.14% | Baird | David Rescott62% | $73 → $68 | Maintains | Neutral | Get Alert |
| 10/11/2024 | Buy Now | -1.33% | Morgan Stanley | Patrick Wood53% | → $70 | Reinstates | → Equal-Weight | Get Alert |
| 10/08/2024 | Buy Now | 5.72% | RBC Capital | Shagun Singh57% | $85 → $75 | Maintains | Outperform | Get Alert |
| 10/07/2024 | Buy Now | -6.96% | Canaccord Genuity | William Plovanic58% | $77 → $66 | Maintains | Hold | Get Alert |
| 10/01/2024 | Buy Now | -1.33% | Evercore ISI Group | Vijay Kumar53% | $76 → $70 | Maintains | In-Line | Get Alert |
| 10/01/2024 | Buy Now | 8.54% | Citigroup | Joanne Wuensch75% | $83 → $77 | Maintains | Buy | Get Alert |
| 09/18/2024 | Buy Now | -1.33% | Jefferies | Matthew Taylor67% | $85 → $70 | Downgrade | Buy → Hold | Get Alert |
| 09/13/2024 | Buy Now | 0.08% | Truist Securities | Richard Newitter74% | $82 → $71 | Maintains | Hold | Get Alert |
| 09/12/2024 | Buy Now | 26.87% | Oppenheimer | Suraj Kalia54% | $90 → $90 | Maintains | Outperform | Get Alert |
| 09/10/2024 | Buy Now | 5.72% | UBS | Danielle Antalffy57% | $90 → $75 | Maintains | Neutral | Get Alert |
| 09/09/2024 | Buy Now | 12.77% | Barclays | Matt Miksic67% | $90 → $80 | Maintains | Overweight | Get Alert |
| 09/09/2024 | Buy Now | 12.77% | Wells Fargo | Larry Biegelsen69% | $90 → $80 | Maintains | Overweight | Get Alert |
| 07/29/2024 | Buy Now | — | Wolfe Research | Mike Polark55% | — | Upgrade | Underperform → Peer Perform | Get Alert |
| 07/26/2024 | Buy Now | 26.87% | Barclays | Matt Miksic67% | $101 → $90 | Maintains | Overweight | Get Alert |
| 07/26/2024 | Buy Now | 28.28% | Goldman Sachs | David Roman37% | $107 → $91 | Maintains | Buy | Get Alert |
| 07/25/2024 | Buy Now | -1.33% | TD Cowen | Joshua Jennings55% | $100 → $70 | Downgrade | Buy → Hold | Get Alert |
| 07/25/2024 | Buy Now | 26.87% | Wells Fargo | Larry Biegelsen69% | $99 → $90 | Maintains | Overweight | Get Alert |
| 07/25/2024 | Buy Now | 7.13% | Evercore ISI Group | Vijay Kumar53% | $91 → $76 | Maintains | In-Line | Get Alert |
| 07/25/2024 | Buy Now | 19.82% | Deutsche Bank | Pito Chickering67% | $103 → $85 | Maintains | Buy | Get Alert |
| 07/25/2024 | Buy Now | 19.82% | RBC Capital | Shagun Singh57% | $101 → $85 | Maintains | Outperform | Get Alert |
| 07/25/2024 | Buy Now | 15.59% | Truist Securities | Richard Newitter74% | $110 → $82 | Downgrade | Buy → Hold | Get Alert |
| 07/25/2024 | Buy Now | -1.33% | Stifel | Rick Wise74% | $85 → $70 | Maintains | Hold | Get Alert |
| 07/25/2024 | Buy Now | 26.87% | Oppenheimer | Suraj Kalia54% | $100 → $90 | Maintains | Outperform | Get Alert |
| 07/25/2024 | Buy Now | 8.54% | Canaccord Genuity | William Plovanic58% | $85 → $77 | Maintains | Hold | Get Alert |
| 07/25/2024 | Buy Now | 2.9% | Piper Sandler | Adam Maeder65% | $88 → $73 | Maintains | Neutral | Get Alert |
| 07/25/2024 | Buy Now | 5.72% | B of A Securities | Travis Steed59% | $105 → $75 | Downgrade | Buy → Neutral | Get Alert |
| 07/25/2024 | Buy Now | 1.49% | JP Morgan | Robbie Marcus67% | $105 → $72 | Downgrade | Overweight → Neutral | Get Alert |
| 07/25/2024 | Buy Now | -1.33% | Baird | David Rescott62% | $102 → $70 | Downgrade | Outperform → Neutral | Get Alert |
| 07/16/2024 | Buy Now | 55.06% | Truist Securities | Richard Newitter74% | $105 → $110 | Maintains | Buy | Get Alert |
| 07/10/2024 | Buy Now | 49.42% | Citigroup | Joanne Wuensch75% | $105 → $106 | Maintains | Buy | Get Alert |
| 07/02/2024 | Buy Now | 28.28% | Evercore ISI Group | Vijay Kumar53% | $89 → $91 | Maintains | In-Line | Get Alert |
| 05/30/2024 | Buy Now | 50.83% | Goldman Sachs | David Roman37% | → $107 | Initiates | → Buy | Get Alert |
| 05/22/2024 | Buy Now | 48.01% | Citigroup | Joanne Wuensch75% | $98 → $105 | Upgrade | Neutral → Buy | Get Alert |
| 05/14/2024 | Buy Now | 45.19% | Deutsche Bank | Pito Chickering67% | $86 → $103 | Upgrade | Hold → Buy | Get Alert |
| 05/07/2024 | Buy Now | 42.37% | Barclays | Matt Miksic67% | $100 → $101 | Maintains | Overweight | Get Alert |
| 04/26/2024 | Buy Now | 19.82% | Canaccord Genuity | William Plovanic58% | $86 → $85 | Maintains | Hold | Get Alert |
| 04/26/2024 | Buy Now | 39.55% | Wells Fargo | Larry Biegelsen69% | $94 → $99 | Maintains | Overweight | Get Alert |
| 04/26/2024 | Buy Now | 25.46% | Evercore ISI Group | Vijay Kumar53% | $92 → $89 | Maintains | In-Line | Get Alert |
| 04/26/2024 | Buy Now | 19.82% | Stifel | Rick Wise74% | $83 → $85 | Maintains | Hold | Get Alert |
| 04/26/2024 | Buy Now | 24.05% | Piper Sandler | Adam Maeder65% | $85 → $88 | Maintains | Neutral | Get Alert |
| 04/15/2024 | Buy Now | 42.37% | RBC Capital | Shagun Singh57% | $95 → $101 | Maintains | Outperform | Get Alert |
| 04/11/2024 | Buy Now | 48.01% | Mizuho | Anthony Petrone64% | $95 → $105 | Maintains | Buy | Get Alert |
| 04/04/2024 | Buy Now | 29.69% | Evercore ISI Group | Vijay Kumar53% | $86 → $92 | Maintains | In-Line | Get Alert |
| 04/03/2024 | Buy Now | 38.14% | Citigroup | Joanne Wuensch75% | $90 → $98 | Maintains | Neutral | Get Alert |
| 03/26/2024 | Buy Now | — | OTR Global | — | — | Upgrade | Mixed → Positive | Get Alert |
| 03/21/2024 | Buy Now | 45.19% | Morgan Stanley | Patrick Wood53% | $95 → $103 | Maintains | Overweight | Get Alert |
| 03/18/2024 | Buy Now | 40.96% | Oppenheimer | Suraj Kalia54% | $93 → $100 | Maintains | Outperform | Get Alert |
| 03/07/2024 | Buy Now | — | B of A Securities | Travis Steed59% | — | Upgrade | Neutral → Buy | Get Alert |
| 02/07/2024 | Buy Now | 17% | Stifel | Rick Wise74% | $70 → $83 | Maintains | Hold | Get Alert |
| 02/07/2024 | Buy Now | 33.92% | Morgan Stanley | Patrick Wood53% | $80 → $95 | Maintains | Overweight | Get Alert |
| 02/07/2024 | Buy Now | 33.92% | RBC Capital | Shagun Singh57% | $82 → $95 | Maintains | Outperform | Get Alert |
| 02/07/2024 | Buy Now | 33.92% | Mizuho | Anthony Petrone64% | $85 → $95 | Maintains | Buy | Get Alert |
| 02/02/2024 | Buy Now | 32.51% | Wells Fargo | Larry Biegelsen69% | → $94 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 01/12/2024 | Buy Now | 15.59% | RBC Capital | Shagun Singh57% | $80 → $82 | Maintains | Outperform | Get Alert |
| 01/04/2024 | Buy Now | 8.54% | Evercore ISI Group | Vijay Kumar53% | $80 → $77 | Downgrade | Outperform → In-Line | Get Alert |
| 12/22/2023 | Buy Now | 18.41% | Truist Securities | Richard Newitter74% | $78 → $84 | Maintains | Buy | Get Alert |
| 12/11/2023 | Buy Now | 9.95% | Truist Securities | Richard Newitter74% | $76 → $78 | Maintains | Buy | Get Alert |
| 12/11/2023 | Buy Now | — | Citigroup | Joanne Wuensch75% | — | Downgrade | Buy → Neutral | Get Alert |
| 12/04/2023 | Buy Now | 12.77% | Morgan Stanley | Patrick Wood53% | $102 → $80 | Maintains | Overweight | Get Alert |
| 11/28/2023 | Buy Now | -19.65% | Wolfe Research | Mike Polark55% | → $57 | Downgrade | Peer Perform → Underperform | Get Alert |
| 10/26/2023 | Buy Now | -1.33% | Stifel | Rick Wise74% | $87 → $70 | Maintains | Hold | Get Alert |
| 10/26/2023 | Buy Now | 19.82% | Mizuho | Anthony Petrone64% | $90 → $85 | Maintains | Buy | Get Alert |
| 10/26/2023 | Buy Now | 7.13% | Truist Securities | Richard Newitter74% | $83 → $76 | Maintains | Buy | Get Alert |
| 10/26/2023 | Buy Now | 15.59% | RBC Capital | Shagun Singh57% | $86 → $82 | Maintains | Outperform | Get Alert |
| 10/26/2023 | Buy Now | -4.14% | Piper Sandler | Adam Maeder65% | $83 → $68 | Maintains | Neutral | Get Alert |
| 10/26/2023 | Buy Now | 19.82% | Citigroup | Joanne Wuensch75% | $94 → $85 | Maintains | Buy | Get Alert |
| 10/26/2023 | Buy Now | 5.72% | Wells Fargo | Larry Biegelsen69% | $88 → $75 | Maintains | Equal-Weight | Get Alert |
| 10/16/2023 | Buy Now | 5.72% | Leerink Partners | Mike Kratky64% | → $75 | Initiates | → Market Perform | Get Alert |
| 10/02/2023 | Buy Now | 32.51% | Citigroup | Joanne Wuensch75% | $110 → $94 | Maintains | Buy | Get Alert |
| 09/26/2023 | Buy Now | 26.87% | Oppenheimer | Suraj Kalia54% | → $90 | Upgrade | Perform → Outperform | Get Alert |
| 09/08/2023 | Buy Now | 17% | Piper Sandler | Adam Maeder65% | $88 → $83 | Maintains | Neutral | Get Alert |
| 08/17/2023 | Buy Now | 35.33% | RBC Capital | Shagun Singh57% | → $96 | Reiterates | Outperform → Outperform | Get Alert |
| 08/01/2023 | Buy Now | 35.33% | RBC Capital | Shagun Singh57% | → $96 | Reiterates | Outperform → Outperform | Get Alert |
| 07/27/2023 | Buy Now | 43.78% | Morgan Stanley | Patrick Wood53% | $102 → $102 | Reiterates | Overweight → Overweight | Get Alert |
| 07/27/2023 | Buy Now | 35.33% | RBC Capital | Shagun Singh57% | → $96 | Reiterates | Outperform → Outperform | Get Alert |
| 07/27/2023 | Buy Now | 40.96% | JP Morgan | Robbie Marcus67% | $95 → $100 | Maintains | Overweight | Get Alert |
| 07/25/2023 | Buy Now | 50.83% | Jefferies | Matthew Taylor67% | $103 → $107 | Maintains | Buy | Get Alert |
| 07/19/2023 | Buy Now | 48.01% | Truist Securities | Richard Newitter74% | $101 → $105 | Maintains | Buy | Get Alert |
| 07/19/2023 | Buy Now | 50.83% | Baird | David Rescott62% | → $107 | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for Edwards Lifesciences (EW) stock?
The latest price target for Edwards Lifesciences (NYSE:EW) was reported by Barclays on February 13, 2025. The analyst firm set a price target for $90.00 expecting EW to rise to within 12 months (a possible 26.87% upside). 65 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Edwards Lifesciences (EW)?
The latest analyst rating for Edwards Lifesciences (NYSE:EW) was provided by Barclays, and Edwards Lifesciences maintained their overweight rating.
When was the last upgrade for Edwards Lifesciences (EW)?
The last upgrade for Edwards Lifesciences Corp happened on January 30, 2025 when Stifel raised their price target to $90. Stifel previously had a hold for Edwards Lifesciences Corp.
When was the last downgrade for Edwards Lifesciences (EW)?
The last downgrade for Edwards Lifesciences Corp happened on January 16, 2025 when Wolfe Research changed their price target from $60 to $60 for Edwards Lifesciences Corp.
When is the next analyst rating going to be posted or updated for Edwards Lifesciences (EW)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Edwards Lifesciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Edwards Lifesciences was filed on February 13, 2025 so you should expect the next rating to be made available sometime around February 13, 2026.
Is the Analyst Rating Edwards Lifesciences (EW) correct?
While ratings are subjective and will change, the latest Edwards Lifesciences (EW) rating was a maintained with a price target of $88.00 to $90.00. The current price Edwards Lifesciences (EW) is trading at is $70.94, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.